237 related articles for article (PubMed ID: 22426079)
1. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples.
Didelot A; Le Corre D; Luscan A; Cazes A; Pallier K; Emile JF; Laurent-Puig P; Blons H
Exp Mol Pathol; 2012 Jun; 92(3):275-80. PubMed ID: 22426079
[TBL] [Abstract][Full Text] [Related]
2. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
3. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
Li G; Luo X; He J; Zhu Z; Yu G; Qin H; Zeng T; Liu Z; Wu S; Xu J; Ren-Heidenreich L
Clin Chem Lab Med; 2011 Feb; 49(2):191-5. PubMed ID: 21118047
[TBL] [Abstract][Full Text] [Related]
4. Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.
Dufort S; Richard MJ; de Fraipont F
Anal Biochem; 2009 Aug; 391(2):166-8. PubMed ID: 19464247
[TBL] [Abstract][Full Text] [Related]
5. Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.
Fadhil W; Ibrahem S; Seth R; Ilyas M
J Clin Pathol; 2010 Feb; 63(2):134-40. PubMed ID: 20154035
[TBL] [Abstract][Full Text] [Related]
6. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
[TBL] [Abstract][Full Text] [Related]
7. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
Gailey MP; Stence AA; Jensen CS; Ma D
Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
[TBL] [Abstract][Full Text] [Related]
8. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis.
van Eijk R; Stevens L; Morreau H; van Wezel T
Exp Mol Pathol; 2013 Feb; 94(1):121-5. PubMed ID: 22750048
[TBL] [Abstract][Full Text] [Related]
10. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
Lamy A; Blanchard F; Le Pessot F; Sesboüé R; Di Fiore F; Bossut J; Fiant E; Frébourg T; Sabourin JC
Mod Pathol; 2011 Aug; 24(8):1090-100. PubMed ID: 21516079
[TBL] [Abstract][Full Text] [Related]
11. Optimization of melting analysis with TaqMan probes for detection of KRAS, NRAS, and BRAF mutations.
Botezatu IV; Nechaeva IO; Stroganova АМ; Senderovich AI; Kondratova VN; Shelepov VP; Lichtenstein AV
Anal Biochem; 2015 Dec; 491():75-83. PubMed ID: 26384642
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
Ishige T; Itoga S; Sato K; Kitamura K; Nishimura M; Sawai S; Matsushita K; Suzuki K; Ota S; Miyauchi H; Matsubara H; Nakatani Y; Nomura F
Clin Biochem; 2014 Dec; 47(18):340-3. PubMed ID: 25262986
[TBL] [Abstract][Full Text] [Related]
13. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL
Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679
[TBL] [Abstract][Full Text] [Related]
14. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
[TBL] [Abstract][Full Text] [Related]
15. Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.
Lv N; Lin S; Xie Z; Tang J; Ge Q; Wu M; Xie X; Xie X; Wei W
Cancer Epidemiol; 2012 Aug; 36(4):341-6. PubMed ID: 22386733
[TBL] [Abstract][Full Text] [Related]
16. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
[TBL] [Abstract][Full Text] [Related]
17. BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M; Shioda Y; Iwafuchi H; Yamazaki S; Iijima K; Takahashi C; Ono H; Uchida K; Okamura O; Matubayashi M; Okuyama T; Matsumoto K; Yoshioka T; Nakazawa A
Diagn Pathol; 2016 Apr; 11():39. PubMed ID: 27094161
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutation analysis in genomic DNA isolated from formalin-fixed paraffin-embedded ovarian tissue: evaluation of a strip-based reverse-hybridisation assay.
Kriegshäuser G; Auner V; Schuster E; Holzer B; Oberkanins C; Horvat R; Speiser P; Zeillinger R
J Clin Pathol; 2011 Mar; 64(3):252-6. PubMed ID: 21258089
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific PCR method for identification of EGFR mutations in non-small cell lung cancer: formalin-fixed paraffin-embedded tissue versus fresh tissue.
Suciu BA; Pap Z; Dénes L; Brînzaniuc K; Copotoiu C; Pávai Z
Rom J Morphol Embryol; 2016; 57(2):495-500. PubMed ID: 27516024
[TBL] [Abstract][Full Text] [Related]
20. KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay.
Jakubauskas A; Griskevicius L
Arch Pathol Lab Med; 2010 Apr; 134(4):620-4. PubMed ID: 20367313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
